Profitability Summary
Innovative Medtech Inc's profitability score is50/100.We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
50/100
Profitability
Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
50/100
Profitability
Score
Past Growth
To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.
Margins
Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.
Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Earnings Waterfall
Innovative Medtech Inc
Earnings Waterfall
Innovative Medtech Inc
Revenue | 0USD |
Operating Expenses | -336kUSD |
Operating Income | -336kUSD |
Other Expenses | -29.4kUSD |
Net Income | -365.3kUSD |
Margins Comparison
Innovative Medtech Inc Competitors
Margins Comparison
Innovative Medtech Inc Competitors
| Country | Company | Market Cap | Gross Margin | Operating Margin | Net Margin | ||
|---|---|---|---|---|---|---|---|
| US | I | Innovative Medtech IncOTC:IMTH | 10.7mUSD | N/A | N/A | N/A | |
| UK | S | Shaftesbury Capital PLCJSE:SHC | 3TZac | 74% | 53% | 385% | |
| CA | A | Advance Lithium CorpXTSX:AALI | 488.6BCAD | N/A | N/A | N/A | |
| US | G | Gould Investors LPOTC:GDVTZ | 300.1BUSD | N/A | N/A | N/A | |
| US | C | Carson Energy Development CorpOTC:CDVM | 270.6BUSD | 10% | -340% | -374% | |
| IN | A | Aaswa Trading and Exports LtdBSE:512038 | 16.3TINR | 79% | 85% | 68% | |
| NL | N | Nepi Rockcastle NVJSE:NRP | 80.4BZac | 64% | 59% | 62% | |
| US | Liberty Bancshares IncOTC:LBSI | 55.5BUSD | N/A | N/A | N/A | ||
| US | Ergo Science CorpOTC:ERGN | 55.2BUSD | 32% | -21% | -17% | ||
| US | H | HK Graphene Technology CorpOTC:HKGT | 53.9BUSD | N/A | N/A | N/A | |
| ID | Amman Mineral Internasional Tbk PTIDX:AMMN | 839.4TIDR | 58% | 54% | 39% |
| Country | US |
| Market Cap | 10.7mUSD |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Margin | N/A |
| Country | UK |
| Market Cap | 3TZac |
| Gross Margin | 74% |
| Operating Margin | 53% |
| Net Margin | 385% |
| Country | CA |
| Market Cap | 488.6BCAD |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Margin | N/A |
| Country | US |
| Market Cap | 300.1BUSD |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Margin | N/A |
| Country | US |
| Market Cap | 270.6BUSD |
| Gross Margin | 10% |
| Operating Margin | -340% |
| Net Margin | -374% |
| Country | IN |
| Market Cap | 16.3TINR |
| Gross Margin | 79% |
| Operating Margin | 85% |
| Net Margin | 68% |
| Country | NL |
| Market Cap | 80.4BZac |
| Gross Margin | 64% |
| Operating Margin | 59% |
| Net Margin | 62% |
| Country | US |
| Market Cap | 55.5BUSD |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Margin | N/A |
| Country | US |
| Market Cap | 55.2BUSD |
| Gross Margin | 32% |
| Operating Margin | -21% |
| Net Margin | -17% |
| Country | US |
| Market Cap | 53.9BUSD |
| Gross Margin | N/A |
| Operating Margin | N/A |
| Net Margin | N/A |
| Country | ID |
| Market Cap | 839.4TIDR |
| Gross Margin | 58% |
| Operating Margin | 54% |
| Net Margin | 39% |
Return on Capital
Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.
13%
ROE
| Oct 31, 2014 | 13% |
| Jul 31, 2014 | 3% |
-59 892%
ROA
| Oct 31, 2014 | -59 892% |
| Jul 31, 2014 | 0% |
12%
ROCE
| Oct 31, 2014 | 12% |
| Jul 31, 2014 | 11% |
22%
ROIC
| Oct 31, 2014 | 22% |
| Jul 31, 2014 | 18% |
Return on Capital Comparison
Innovative Medtech Inc Competitors
Return on Capital Comparison
Innovative Medtech Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US | I | Innovative Medtech IncOTC:IMTH | 10.7mUSD | 13% | -59 892% | 12% | 22% | |
| UK | S | Shaftesbury Capital PLCJSE:SHC | 3TZac | 30% | 20% | 3% | 3% | |
| CA | A | Advance Lithium CorpXTSX:AALI | 488.6BCAD | -192% | -148% | -35% | -34% | |
| US | G | Gould Investors LPOTC:GDVTZ | 300.1BUSD | N/A | N/A | N/A | N/A | |
| US | C | Carson Energy Development CorpOTC:CDVM | 270.6BUSD | 3 074% | -4 246% | 3 656% | 21 158% | |
| IN | A | Aaswa Trading and Exports LtdBSE:512038 | 16.3TINR | 162% | 146% | 202% | 163% | |
| NL | N | Nepi Rockcastle NVJSE:NRP | 80.4BZac | 12% | 6% | 7% | 6% | |
| US | Liberty Bancshares IncOTC:LBSI | 55.5BUSD | N/A | N/A | N/A | N/A | ||
| US | Ergo Science CorpOTC:ERGN | 55.2BUSD | -23% | -14% | -29% | -19% | ||
| US | H | HK Graphene Technology CorpOTC:HKGT | 53.9BUSD | 76% | -75% | 73% | N/A | |
| ID | Amman Mineral Internasional Tbk PTIDX:AMMN | 839.4TIDR | N/A | N/A | N/A | N/A |
| Country | US |
| Market Cap | 10.7mUSD |
| ROE | 13% |
| ROA | -59 892% |
| ROCE | 12% |
| ROIC | 22% |
| Country | UK |
| Market Cap | 3TZac |
| ROE | 30% |
| ROA | 20% |
| ROCE | 3% |
| ROIC | 3% |
| Country | CA |
| Market Cap | 488.6BCAD |
| ROE | -192% |
| ROA | -148% |
| ROCE | -35% |
| ROIC | -34% |
| Country | US |
| Market Cap | 300.1BUSD |
| ROE | N/A |
| ROA | N/A |
| ROCE | N/A |
| ROIC | N/A |
| Country | US |
| Market Cap | 270.6BUSD |
| ROE | 3 074% |
| ROA | -4 246% |
| ROCE | 3 656% |
| ROIC | 21 158% |
| Country | IN |
| Market Cap | 16.3TINR |
| ROE | 162% |
| ROA | 146% |
| ROCE | 202% |
| ROIC | 163% |
| Country | NL |
| Market Cap | 80.4BZac |
| ROE | 12% |
| ROA | 6% |
| ROCE | 7% |
| ROIC | 6% |
| Country | US |
| Market Cap | 55.5BUSD |
| ROE | N/A |
| ROA | N/A |
| ROCE | N/A |
| ROIC | N/A |
| Country | US |
| Market Cap | 55.2BUSD |
| ROE | -23% |
| ROA | -14% |
| ROCE | -29% |
| ROIC | -19% |
| Country | US |
| Market Cap | 53.9BUSD |
| ROE | 76% |
| ROA | -75% |
| ROCE | 73% |
| ROIC | N/A |
| Country | ID |
| Market Cap | 839.4TIDR |
| ROE | N/A |
| ROA | N/A |
| ROCE | N/A |
| ROIC | N/A |
Free Cash Flow
Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.
If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.
-4.4k
Operating Cash Flow
| Oct 31, 2014 | -4.4k |
| Jul 31, 2014 | 0 |
Capital Expenditures
| Oct 31, 2014 | 0 |
| Jul 31, 2014 | 0 |
-4.4k
Free Cash Flow
| Oct 31, 2014 | -4.4k |
| Jul 31, 2014 | 0 |
See Also
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
